Skip to Main Content
Raquibul Hannan, M.D.,  Ph.D.

Raquibul Hannan, M.D., Ph.D.

Chief of Genitourinary Radiation Oncology Service

Professor

School
Medical School
Department
Radiation Oncology | Immunology | Urology
Graduate Programs
Cancer Biology

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

  • Education
    Graduate School
    SUNY Downstate Medical Center (2002)
    Medical School
    SUNY Downstate Medical Center (2006)
    Internship
    SUNY Downstate Medical Center (2007), Internal Medicine
    Residency
    Montefiore Med. Ctr. & Albert Einstein College of Med. (2011), Radiation Oncology
  • Research Interest
    • Improve cancer patient treatment outcome through the design of i-SAbR clinical trials
    • Innate and adaptive immune responses generated by tumor irradiation with stereotactic ablative radiotherapy (SAbR)
    • Investigate strategies to combine immunotherapy with SAbR (i-SAbR) for cancer treatment
  • Publications
    Corrigendum to “Androgen Deprivation and Radiotherapy with or Without Docetaxel for Localized High-risk Prostat Cancer: Long-term Follow-up from the Randomized NRG Oncology RTOG 0521 Trial” [Eur. Eurol. 84(2) (2023) 156–163, (S0302283823027884), (10.1016/j.eururo.2023.04.024)]
    Sartor O, Karrison TG, Sandler HM, Gomella LG, Amin M, Purdy J, Michalski JM, Garzotto MG, Pervez N, Balogh AG, Rodrigues GB, Souhami L, Neil Reaume M, Williams SG, Hannan R, Jones CU, Horwitz EM, Rodgers JP, Feng FY, Rosenthal SA European urology 2024 Sep 86 289-290
    Performance deterioration of deep learning models after clinical deployment: a case study with auto-segmentation for definitive prostate cancer radiotherapy
    Wang B, Dohopolski M, Bai T, Wu J, Hannan R, Desai N, Garant A, Yang D, Nguyen D, Lin MH, Timmerman R, Wang X, Jiang SB Machine Learning: Science and Technology 2024 Jun 5
    Noninferiority of Hypofractionated vs Conventional Postprostatectomy Radiotherapy for Genitourinary and Gastrointestinal Symptoms: The NRG-GU003 Phase 3 Randomized Clinical Trial
    Buyyounouski MK, Pugh SL, Chen RC, Mann MJ, Kudchadker RJ, Konski AA, Mian OY, Michalski JM, Vigneault E, Valicenti RK, Barkati M, Lawton CA, Potters L, Monitto DC, Kittel JA, Schroeder TM, Hannan R, Duncan CE, Rodgers JP, Feng F, Sandler HM JAMA Oncology 2024 May 10 584-591
    Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma—a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology
    Marvaso G, Jereczek-Fossa BA, Zaffaroni M, Vincini MG, Corrao G, Andratschke N, Balagamwala EH, Bedke J, Blanck O, Capitanio U, Correa RJ, De Meerleer G, Franzese C, Gaeta A, Gandini S, Garibaldi C, Gerszten PC, Gillessen S, Grubb WR, Guckenberger M, Hannan R, Jhaveri PM, Josipovic M, Kerkmeijer LG, Lehrer EJ, Lindskog M, Louie AV, Nguyen QN, Ost P, Palma DA, Procopio G, Rossi M, Staehler M, Tree AC, Tsang YM, Van As N, Zaorsky NG, Zilli T, Pasquier D, Siva S The Lancet Oncology 2024 May 25 e193-e204
    Targeted chemotherapy via HER2-based chimeric antigen receptor (CAR) engineered T-cell membrane coated polymeric nanoparticles
    Yaman S, Ramachandramoorthy H, Iyer P, Chintapula U, Nguyen T, Sabnani M, Kotadia T, Ghaffari S, Pop LM, Hannan R, Weidanz JA, Nguyen KT Bioactive Materials 2024 Apr 34 422-435
    Harnessing stereotactic precision in the fight against primary kidney cancer: time for a randomised trial?
    Yang DX, Hannan R The Lancet Oncology 2024 Mar 25 267-269
    Stereotactic ablative radiotherapy for primary renal cell carcinoma
    Yang DX, Kwon YS, Timmerman R, Hannan R Clinical and Translational Radiation Oncology 2024 Jan 44
    Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma: A Case-Based Radiosurgery Society Practice Guide
    Barbour AB, Upadhyay R, Anderson AC, Kutuk T, Kumar R, Wang SJ, Psutka SP, Fekrmandi F, Skalina KA, Bruynzeel AM, Correa RJ, Dal Pra A, Biancia CD, Hannan R, Louie A, Singh AK, Swaminath A, Tang C, Teh BS, Zaorsky NG, Lo SS, Siva S Practical Radiation Oncology 2024
    Radiation-Induced Innate Neutrophil Response in Tumor Is Mediated by the CXCLs/CXCR2 Axis
    Zhang F, Mulvaney O, Salcedo E, Manna S, Zhu JZ, Wang T, Ahn C, Pop LM, Hannan R Cancers 2023 Dec 15
    Bony structure enhanced synthetic CT generation using Dixon sequences for pelvis MR-only radiotherapy
    Liang X, Yen A, Bai T, Godley A, Shen C, Wu J, Meng B, Lin MH, Medin P, Yan Y, Owrangi M, Desai N, Hannan R, Garant A, Jiang S, Deng J Medical physics 2023 Dec 50 7368-7382
  • Honors & Awards
    • Radiation and Cancer Biology Poster Award
      ASTRO 52nd Annual Meeting (2010)
    • US Patent
      Pancreatic Cancer-Associated Antigen, Antibody thereto, and Diagnostic and Treatment Methods Development of a PaCa-Ag1-Specific Enzyme-Linked Immuno-Assay (2006)
    • International Patent
      Pancreatic Cancer-Associated Antigen, Antibody thereto, and Diagnostic and Treatment Methods (2005)
  • Professional Associations/Affiliations
    • American Society of Clinical Oncology
    • American Society of Therapeutic Radiology and Oncology